At IFPAC, DIR Technologies to Present Lecture on First Bottle Induction Sealing Inspection Solution Using Dynamic Thermal Imaging

Fabian Schapiro, VP Marketing & Sales for DIR Technologies, to Discuss Non-invasive, 100% Inspection Solution as Part of Session Led by Pfizer

Haifa, Israel – Fabian Schapiro, Vice President of Marketing & Sales for DIR Technologies, will deliver an in-depth presentation discussing the company’s groundbreaking package induction sealing inspection technology during the International Forum on Process Analytical Chemistry Annual Meeting, January 25-28 in Washington, D.C. The lecture will be part of a session led by Steve Hammond, Sr. Director of the Process Analytical Sciences Group at Pfizer Pharmaceuticals, surrounding the use of Process Analytical Technologies (PAT) in optimizing packaging operations.

DIR Technologies employs the science of advanced thermal imaging to develop and offer 100%, entirely non-contact, high-speed packaging induction seal inspection for the pharmaceutical industry. The company, whose name is short for Dynamic Infra-Red Technologies, is the first to successfully introduce this technology to the industry. In doing so, they have made a new level of quality assurance attainable by replacing sporadic, destructive package sampling with continuous, in-line, non-invasive process verification.

Earlier this year, Pfizer announced a three-month trial of DIR Technologies’ I2VS (Induction Integrity Verification System) to test in-line the integrity of the aluminum foil sealing of induction-sealed bottles.  An easily-operated, wheel-up/wheel-away solution, the I2VS is the first system capable of inspecting 100 percent of the bottles undergoing induction sealing, without resulting in production slowdown and providing continuous process verification. Inspection is performed through the cap by means of high-sensitivity thermal imaging in an entirely passive, non-destructive process.

Defects in an induction sealing process can originate at various steps along a packaging line, including the capper, induction machine, conveyor and, of course, the raw material itself. Sampling can only provide an indication of major process problems, and will not identify distinct, possibly even uniquely defective seals that may occur.

In addition to real-time testing of 100% of the products on a line, DIR Technologies’ solutions also offer real-time process monitoring, full records (including images) for every product, and very high throughput without production slowdown.

“Along with our full portfolio of solutions, the I2VS represents a quantum leap forward in sealing integrity inspection and process control, a means of making imprecise sampling a thing of the past,” said Mr. Schapiro of DIR Technologies. “We look forward to presenting this innovative solution in which forward-thinking pharmaceutical manufacturers have already seen great promise.”

About DIR Technologies

Based in Haifa, Israel, DIR Technologies employs the science of advanced thermal imaging to develop and offer 100%, entirely non-contact, high-speed packaging induction seal inspection for the pharmaceutical industry. The company, whose name is short for Dynamic Infra-Red Technologies, is the first to apply this groundbreaking “see-through” technology to broad commercial practice.

DIR Technologies also specializes in image processing, machine vision and real-time data processing and, by using thermal imaging techniques in Process Analytical Technologies (PAT) applications, can build systems that identify and control critical points in a production process. To date, the company possesses several patents related to drug authentication, package integrity, PAT and microbiology.

DIR’s top executives and engineers are among the most knowledgeable in this high-tech field.  Originally, most served in key positions at SemiConductor Devices (www.scd.co.il) (SCD), one of the world’s largest manufacturers of advanced infrared sensors. DIR was established in 2009 and is jointly owned by major Israeli defense companies Rafael Advanced Defense Systems, LTD (www.rafael.co.il) and Elbit Systems (www.elbitsystems.com), and Israeli-American fund SCP Vitalife (www.scpvitalife.com).